NEW YORK (Reuters) - Generic drugmaker Teva Pharmaceutical Industries Ltd. on Tuesday proposed buying Mylan for $40 billion, saying it was a better deal than the smaller rival's offer to buy Perrigo Co.
The bid comes after weeks of speculation that Teva, the world's largest generic company, would make a bid for Mylan.
18:05 DP World, Quebec's Caisse to create C$5 billion investment vehicle17
00:27 Trump warns of ‘retribution’ if companies move jobs out of U.S13
14:49 Trump warns of ‘retribution’ for companies that offshore jobs, threatening 35 percent tariff14
14:45 Spain raises taxes to try to meet EU deficit target14